首页> 外国专利> IMIDAZOLE DERIVATIVE AND THROMBOXANE A2 SYNTHETASE INHIBITOR CONTAINING SAME

IMIDAZOLE DERIVATIVE AND THROMBOXANE A2 SYNTHETASE INHIBITOR CONTAINING SAME

机译:咪唑衍生物和血栓烷A2合成酶抑制剂含量相同

摘要

NEW MATERIAL:The compound of formula I (R1 and R2 are H or CH3; when R1 is H, R2 is also H; the double bond in the parentheses m has trans configuration; m is 1 or 2; n is 2-5). EXAMPLE:1-(3-Methoxy-4-hydroxyphenyl)-5-(imidazol-1-yl)-1-penten-3-one. USE:A medicine. A thromboxane A2-synthesis inhibitor. It has strong effect to suppress the coagulation of platelet, contraction of vessel and contraction of bronchus and is effective for the prevention of stenocardia, myocardial infarction, cerebral infarction, bronchial asthma, etc. It is also expected as an agent for preventing metastasis of cancer because the coagulation of platelet participates in the metastasis of cancer. PREPARATION:The compound of formula I can be produced by reacting the aldehyde derivative of formula (R3 and R4 are CH3 or methoxymethyl; k is number of double bonds having trans configuration and is 0 or 1; when R3 is methoxymethyl, R4 is also methoxymethyl) with a phosphonate derivative of formula III (l is 2-5) in the presence of NaH.
机译:新材料:式I化合物(R 1和R 2为H或CH 3;当R 1为H时,R 2也为H;括号m中的双键具有反式构型; m为1或2; n为2-5)。实施例:1-(3-甲氧基-4-羟基苯基)-5-(咪唑-1-基)-1-戊烯-3-一。用途:一种药物。血栓烷A2合成抑制剂。具有抑制血小板凝结,血管收缩和支气管收缩的强效作用,对预防狭窄性狭窄,心肌梗塞,脑梗塞,支气管哮喘等有效。有望作为预防癌症转移的药物。因为血小板的凝结参与了癌症的转移。制备:式I化合物可通过使式(R 3和R 4为CH 3或甲氧基甲基的醛衍生物; k为具有反式构型的双键的数目为0或1;当R < 3是甲氧基甲基,R 4也是甲氧基甲基)在NaH存在下与式III的膦酸酯衍生物(1是2-5)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号